<p>The major spliceosome includes five small nuclear RNA (snRNAs), U1, U2, U4, U5 and U6, each of which is encoded by multiple genes. We recently showed that mutations in <i>RNU4-</i>2, the gene that encodes the U4-2 snRNA, cause one of the most prevalent monogenic neurodevelopmental disorders. Here, we report that recurrent germline mutations in <i>RNU2-2</i> (previously known as pseudogene <i>RNU2-2P</i>), a 191-bp gene that encodes the U2-2 snRNA, are responsible for a related disorder. By genetic association, we identified recurrent de novo single-nucleotide mutations at nucleotide positions 4 and 35 of <i>RNU2-2</i> in nine cases. We replicated this finding in 16 additional cases, bringing the total to 25. We estimate that <i>RNU2-2</i> syndrome has a prevalence of ~20% that of <i>RNU4-2</i> syndrome. The disorder is characterized by intellectual disability, autistic behavior, microcephaly, hypotonia, epilepsy and hyperventilation. All cases display a severe and complex seizure phenotype. We found that U2-2 and canonical U2-1 were similarly expressed in blood. Despite mutant U2-2 being expressed in patient blood samples, we found no evidence of missplicing. Our findings cement the role of major spliceosomal snRNAs in the etiologies of neurodevelopmental disorders.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Mutations in the small nuclear RNA gene RNU2-2 cause a severe neurodevelopmental disorder with prominent epilepsy

  • Daniel Greene,
  • Koenraad De Wispelaere,
  • Jon Lees,
  • Marta Codina-Solà,
  • Brynjar O. Jensson,
  • Emma Hales,
  • Andrea Katrinecz,
  • Esther Nieto Molina,
  • Sonia Pascoal,
  • Rolph Pfundt,
  • Rachel Schot,
  • Marta Sevilla Porras,
  • Frank Sleutels,
  • Irene Valenzuela,
  • Robin Wijngaard,
  • Ignacio Arroyo Carrera,
  • Giles Atton,
  • Didac Casas-Alba,
  • Deirdre Donnelly,
  • Anna Duat Rodríguez,
  • Bárbara Fernández Garoz,
  • Nicola Foulds,
  • Deyanira García-Navas Núñez,
  • Elena González Alguacil,
  • Joanna Jarvis,
  • Sarina G. Kant,
  • Irene Madrigal Bajo,
  • Antonio F. Martinez-Monseny,
  • Shane McKee,
  • Nelmar Valentina Ortiz Cabrera,
  • Laia Rodríguez-Revenga Bodi,
  • Andrea Sariego Jamardo,
  • Kari Stefansson,
  • Patrick Sulem,
  • Mohnish Suri,
  • Clara Van Karnebeek,
  • Pradeep Vasudevan,
  • Ana Isabel Vega Pajares,
  • Ángel Carracedo,
  • Marc Engelen,
  • Pablo Lapunzina,
  • Natasha P. Morgan,
  • Beatriz Morte,
  • Patrick Rump,
  • Kathy Stirrups,
  • Eduardo F. Tizzano,
  • Tahsin Stefan Barakat,
  • Michael O’Donoghue,
  • Luis Alberto Pérez-Jurado,
  • Kathleen Freson,
  • Andrew D. Mumford,
  • Ernest Turro

摘要

The major spliceosome includes five small nuclear RNA (snRNAs), U1, U2, U4, U5 and U6, each of which is encoded by multiple genes. We recently showed that mutations in RNU4-2, the gene that encodes the U4-2 snRNA, cause one of the most prevalent monogenic neurodevelopmental disorders. Here, we report that recurrent germline mutations in RNU2-2 (previously known as pseudogene RNU2-2P), a 191-bp gene that encodes the U2-2 snRNA, are responsible for a related disorder. By genetic association, we identified recurrent de novo single-nucleotide mutations at nucleotide positions 4 and 35 of RNU2-2 in nine cases. We replicated this finding in 16 additional cases, bringing the total to 25. We estimate that RNU2-2 syndrome has a prevalence of ~20% that of RNU4-2 syndrome. The disorder is characterized by intellectual disability, autistic behavior, microcephaly, hypotonia, epilepsy and hyperventilation. All cases display a severe and complex seizure phenotype. We found that U2-2 and canonical U2-1 were similarly expressed in blood. Despite mutant U2-2 being expressed in patient blood samples, we found no evidence of missplicing. Our findings cement the role of major spliceosomal snRNAs in the etiologies of neurodevelopmental disorders.